Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland

Back to Search
Print
Bookmark Trial

NCT01787565

Last updated date
Back to Search
Print
Bookmark Trial
FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Helsinki, , 00100, Finland
See other locations
Contact
1-800-718-1021
[email protected]
Related Links

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

1-800-718-1021

By email

Contact

[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Back Pain
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- New episode of low back pain

- Member of Terveystalo health insurance scheme

Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details


- Previous back pain related healthcare visit in the last 3 months


- Patients identified as having a 'red flag' condition

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

Call Now
pfizer-logoClinical Trials
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
Learn more ›

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Advanced Search

Based on your search, you may also be interested in

Back PainHeat Wrap Device Safety With Age and Body Fat
NCT01355653
  1. Loma Linda, California
ALL GENDERS
18 Years+
years
MULTIPLE SITES
Back PainPilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland
NCT01787565
  1. Helsinki,
ALL GENDERS
18 Years+
years
MULTIPLE SITES
Back PainCelebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
NCT00290901
  1. Phoenix, Arizona
  2. Scottsdale, Arizona
  3. Tucson, Arizona
  4. Little Rock, Arkansas
  5. Anaheim, California
  6. La Mesa, California
  7. Long Beach, California
  8. Oceanside, California
  9. Paramount, California
  10. Sacramento, California
  11. San Francisco, California
  12. San Luis Obispo, California
  13. Tustin, California
  14. Vista, California
  15. Boulder, Colorado
  16. Colorado Springs, Colorado
  17. Denver, Colorado
  18. Cos Cob, Connecticut
  19. Washington, District of Columbia
  20. Miami, Florida
  21. Pembroke Pines, Florida
  22. West Palm Beach, Florida
  23. Decatur, Georgia
  24. Woodstock, Georgia
  25. Libertyville, Illinois
  26. Morton Grove, Illinois
  27. Arkansas City, Kansas
  28. Overland Park, Kansas
  29. Wichita, Kansas
  30. Madisonville, Kentucky
  31. Baltimore, Maryland
  32. Wheaton, Maryland
  33. Jackson, Mississippi
  34. Kansas City, Missouri
  35. St. Louis, Missouri
  36. Omaha, Nebraska
  37. Brooklyn, New York
  38. New York, New York
  39. Rochester, New York
  40. Raleigh, North Carolina
  41. Medford, Oregon
  42. Portland, Oregon
  43. Camp Hill, Pennsylvania
  44. Duncansville, Pennsylvania
  45. Charleston, South Carolina
  46. Columbia, South Carolina
  47. Johnson City, Tennessee
  48. New Tazewell, Tennessee
  49. Austin, Texas
  50. San Angelo, Texas
  51. San Antonio, Texas
  52. Arlington, Virginia
  53. Danville, Virginia
  54. Rio Piedras,
ALL GENDERS
18 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland
Official Title Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland
Brief Summary The aim of this investigation is to determine whether the use of painPREMIER will significantly improve function in patients with low back pain in an occupational health clinical setting. painPREMIER is a tool that assists clinicians in the accurate diagnosis of back pain and associated problems in order to treat them most effectively.
Detailed Description Patients presenting at feeder sites to be referred to low back pain clinic and assessed for eligibility A decision was made to terminate this study on 09 OCT 2013. The study was terminated for operational/business reasons. This study was not terminated for reasons of safety or efficacy.
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Members of the Terveystalo health insurance scheme presenting with a new episode of low back pain
Condition Back Pain
Intervention
  • Other: painPREMIER cohort
    Low back pain patients prospectively recruited during the study period and managed with painPREMIER.
  • Other: Control cohort
    A matched group of low back pain patients not managed with painPREMIER.
Study Groups/Cohorts
  • painPREMIER cohort
    Intervention: Other: painPREMIER cohort
  • Control cohort
    Intervention: Other: Control cohort
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Terminated
Actual Enrollment
 (submitted: February 12, 2014)		86
Original Estimated Enrollment
 (submitted: February 6, 2013)		200
Actual Study Completion Date January 2014
Actual Primary Completion Date January 2014   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • New episode of low back pain
  • Member of Terveystalo health insurance scheme

Exclusion Criteria:

  • Previous back pain related healthcare visit in the last 3 months
  • Patients identified as having a 'red flag' condition
Sex/Gender
Sexes Eligible for Study:All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Finland
Removed Location Countries  
 
Administrative Information
NCT Number NCT01787565
Other Study ID Numbers X9001016
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Pfizer
Study Sponsor Pfizer
Collaborators Terveystalo
Investigators
Study Director:Pfizer CT.gov Call CenterPfizer
PRS Account Pfizer
Verification Date April 2016